The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
On May 12, 2025, President Trump issued an Executive Order entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” in which he instructed his Administration to create ...
Andwell Health Partners is among nearly 400 organizations selected nationwide to participate in the new Medicare GUIDE Model. The program will support people living with dementia and their caregivers ...
The Trump administration decided to put the pilot on hold until at least 2027.
On April 4, 2025, the Centers for Medicare & Medicaid Services (“CMS”) released the contract year (“CY”) 2026 final rule for the Medicare Advantage (“MA”) program, Medicare Prescription Drug Benefit ...